Cubist Systematic Strategies has increased its short position in Danish pharmaceutical company Genmab to 0.57 percent of the share capital, corresponding to 356,653 shares. The firm is therefore a new publicly disclosed short seller in the company.
In total, 1.71 percent of Genmab’s share capital is shorted.
Finanstilsynet requires positions exceeding 0.1 percent to be reported and short positions exceeding 0.5 percent to be made public.
